Intravascular Ultrasound Evaluation of Optimal Drug-Eluting Stent Expansion After Poststent Balloon Dilation Using a Noncompliant Balloon Versus a Semicompliant Balloon (from the Poststent Optimal Stent Expansion Trial [POET])

American Journal of Cardiology

Volumn 102, Issue 3, 2008, Pages 304-310

  Kim, Jung Sun ^a   Moon, Jae Youn ^b   Ko, Young Guk ^a   Choi, Donghoon ^a   Jang, Yangsoo ^a   Kang, Woong Chol ^c   Ahn, Taehoon ^c   Kim, Byoung Keuk ^d   Oh, Seong Jin ^d   Jeon, Dong Woon ^d   Yang, Joo Young ^d  

^a Yonsei University College of Medicine   (South Korea)

^b CHA University   (South Korea)

^c Gachon University College of Medicine   (South Korea)

^d National Health Insurance Corporation   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ARTICLE; BALLOON CATHETER; BALLOON DILATATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ELUTING STENT; EVALUATION; FEMALE; HUMAN; INCIDENCE; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; PROSPECTIVE STUDIES; SIROLIMUS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 51749091530     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.03.059     Document Type: Article

References (16)

1. Desmet W.J., De Scheerder I.K., Barrios L., and Piessens J.H. Comparison of clinical complications, angiographic results, and device usage of coronary angioplasty using low- and high-compliance balloons. Catheter Cardiovasc Diagn 41 (1997) 5-11
2. de Jaegere P., Mudra H., Figulla H., Almagor Y., Doucet S., Penn I., Colombo A., Hamm C., Bartorelli A., Rothman M., et al. Intravascular ultrasound-guided optimized stent deployment. Immediate and 6 months clinical and angiographic results from the Multicenter Ultrasound Stenting in Coronaries Study (MUSIC Study). Eur Heart J 19 (1998) 1214-1223
3. Hur S.H., Kitamura K., Morino Y., Honda Y., Jones M., Korr K.S., Reen III B., Cooper C.J., Niess G.S., Christie L., et al. Efficacy of postdeployment balloon dilatation for current generation stents as assessed by intravascular ultrasound. Am J Cardiol 88 (2001) 1114-1119
4. Brodie B.R. Adjunctive balloon postdilatation after stent deployment: is it still necessary with drug-eluting stents?. J Interv Cardiol 19 (2006) 43-50
5. Roberts D.K. H.H., Kitamura K., Luna J., Page R.D., Fehrenbacher G.H.H., Stephens C.A., Parise C.M., and Fitzgerald P.J. The impact of non-compliant balloon materials on balloon delivered coronary stent expansion. Circulation 102 suppl 2 (2000) II547
6. Iakovou I., Schmidt T., Bonizzoni E., Ge L., Sangiorgi G.M., Stankovic G., Airoldi F., Chieffo A., Montorfano M., Carlino M., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
7. Ong A.T., Hoye A., Aoki J., van Mieghem C.A., Rodriguez Granillo G.A., Sonnenschein K., Regar E., McFadden E.P., Sianos G., van der Giessen W.J., et al. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol 45 (2005) 947-953
8. Moreno R., Fernandez C., Hernandez R., Alfonso F., Angiolillo D.J., Sabate M., Escaned J., Banuelos C., Fernandez-Ortiz A., and Macaya C. Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 45 (2005) 954-959
9. Fujii K., Carlier S.G., Mintz G.S., Yang Y.M., Moussa I., Weisz G., Dangas G., Mehran R., Lansky A.J., Kreps E.M., et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol 45 (2005) 995-998
10. Sonoda S., Morino Y., Ako J., Terashima M., Hassan A.H., Bonneau H.N., Leon M.B., Moses J.W., Yock P.G., Honda Y., Kuntz R.E., and Fitzgerald P.J. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the Sirius trial. J Am Coll Cardiol 43 (2004) 1959-1963
11. Hong M.K., Mintz G.S., Lee C.W., Park D.W., Choi B.R., Park K.H., Kim Y.H., Cheong S.S., Song J.K., Kim J.J., Park S.W., and Park S.J. Intravascular ultrasound predictors of angiographic restenosis after sirolimus-eluting stent implantation. Eur Heart J 27 (2006) 1305-1310
12. Cheneau E., Satler L.F., Escolar E., Suddath W.O., Kent K.M., Weissman N.J., Waksman R., and Pichard A.D. Underexpansion of sirolimus-eluting stents: incidence and relationship to delivery pressure. Catheter Cardiovasc Interv 65 (2005) 222-226
13. Javaid A., Chu W.W., Cheneau E., Clavijo L.C., Satler L.F., Kent K.M., Weissman N.J., Pichard A.D., and Waksman R. Comparison of paclitaxel-eluting stent and sirolimus-eluting stent expansion at incremental delivery pressures. Cardiovasc Revasc Med 7 (2006) 208-211
14. Mintz G.S., Hoffmann R., Mehran R., Pichard A.D., Kent K.M., Satler L.F., Popma J.J., and Leon M.B. In-stent restenosis: the Washington Hospital Center experience. Am J Cardiol 81 suppl (1998) 7E-13E
15. Goldberg S.L., Di Mario C., Hall P., and Colombo A. Comparison of aggressive versus nonaggressive balloon dilatation for stent deployment on late loss and restenosis in native coronary arteries. Am J Cardiol 81 (1998) 708-712
16. Morino Y., Honda Y., Okura H., Oshima A., Hayase M., Bonneau H.N., Kuntz R.E., Yock P.G., and Fitzgerald P.J. An optimal diagnostic threshold for minimal stent area to predict target lesion revascularization following stent implantation in native coronary lesions. Am J Cardiol 88 (2001) 301-303